SHARE

News Alert: Citius Pharmaceuticals Receives FDA Approval For LYMPHIR™ (Denileukin Diftitox-Cxdl) Immunotherapy For The Treatment Of Adults With Relapsed Or Refractory Cutaneous T-Cell Lymphoma. Click to Read More.

Marijuana Company Of America Inc (OTCMKTS:MCOA) reported that after many months of R&D business planning and development, it has now started generating revenue and began to ship orders for its ‘hempSMART’ Brain product.

The management speaks

Donald Steinberg, the CEO of Marijuana Company, said that revenue report to prospective and current shareholders is a vital measure as the firm continues to extend its footprint across U.S. Now that they have laid the base for affiliate program in the U.S., the company’s objective is to use its global networks and contacts to begin expansion of the hempSMART brand in many other nations. In the past Steinberg has advanced one of the largest affiliate programs in the globe, with offices in more than 50 nations and an affiliate base of more than 100,000 members. Now, he will use that experience as it expands the hempSMART brand.

Tim Altvater, the Marketing Director of Marijuana Company, said that the hempSMART product launch is a great achievement, particularly for marketers in the direct sales market. Now they can focus on the advancement of affiliate network as folks begin to utilize and share their understandings with hempSMART Brain and the advantages of the hempSMART rewards and compensation program. The ability for entrepreneurs to show the premium products, backed by science, to customers that are in need and wanting them is the driver for industry’s sustained expansion and appeal. They are poised to witness unprecedented growth as they close FY2016 strong!”

Marijuana Company’s inaugural product, ‘hempSMART Brain’, is formulated with Cannabidiol or CBD as the core ingredient and high quality branded ingredients. The additional ingredients compliment the CBD to boost brain health. The product is formulated to satiate the budding demand for neutraceutical products. It is a first-of-its-kind offering with a synergistic blend of branded ingredients, blended with CBD to get optimum bioavailability for brain support.

In last trading session, the stock price of Marijuana Company declined over 17% to close at $0.0480. The decline came at a share volume of 24.73 million compared to average share volume of 33.17 million.